| Literature DB >> 34104172 |
Mst Romena Khatun1, Kh Md Faisal Alam2, Mahmuda Naznin3, Md Abdus Salam4.
Abstract
OBJECTIVES: Chronic suppurative otitis media is a major cause of acquired hearing impairment, especially in children of developing countries. The study sought to explore the bacteriological profile and their antimicrobial susceptibility among patients of chronic suppurative otitis media from a tertiary care hospital in Bangladesh.Entities:
Keywords: Antibiogram; Bangladesh; CSOM; Multidrug-resistance; Tertiary care hospital
Year: 2021 PMID: 34104172 PMCID: PMC8155403 DOI: 10.12669/pjms.37.3.3942
Source DB: PubMed Journal: Pak J Med Sci ISSN: 1681-715X Impact factor: 1.088
Fig.1Frequency distribution of bacteria isolated from CSOM patients (n=73).
Pattern of polymicrobial growths from CSOM patients.
| Bacterial combination | n (%) |
|---|---|
| S. aureus + E. coli | 2 (2.9) |
| S. aureus + K. pneumoniae | 2 (2.9) |
| P. aeruginosa + CoNS | 1 (1.5) |
| Total | 5 (7.3) |
Antimicrobial susceptibility pattern of bacteria from CSOM patients (n=73).
| Bacteria | n (%) of bacteria susceptible towards different antibiotics | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| AMC | CTX | CAZ | CRO | CPM | IMP | DA | VAN | LZ | CIP | GN | PTZ | |
| S. aureus | 10 (37) | 23 (85.2) | 10 (37) | 14 (52) | - | 26 (96.3) | 09 (33.3) | 27 (100) | 27 (100) | 15 (55.5) | 22 (81.4) | - |
| CoNS | 3 (50) | 6 (100) | 3 (50) | 4 (66.7) | - | 5 (83) | 3 (50) | 6 (100) | 6 (100) | 4 (66.7) | 5 (83) | - |
| P. aeruginosa | 6 (26.1) | - | 10 (43.5) | 11 (47.8) | 18 (78.2) | 22 (95.6) | - | - | - | 15 (65.2) | 19 (82.6) | 22 (95.6) |
| E. coli | 3 (30) | - | 6 (60) | 5 (50) | 7 (70) | 8 (80) | - | - | - | 7 (70) | 7 (70) | 9 (90) |
| K. pneumoniae | 1 (25) | - | 2 (50) | 2 (50) | 3 (75) | 4 (100) | - | - | - | 2 (50) | 3 (75) | 3 (75) |
| Proteus spp. | 1 (33.3) | - | 1 (33.3) | 1 (33.3) | 2 (66.7) | 2 (66.7) | - | - | - | 2 (66.7) | 2 (66.7) | 2 (66.7) |
AMC- Amoxicillin/Clavulanate, CTX-Cefoxitin, CAZ-Ceftazidime, CRO-Ceftriaxone, CPM-Cefepime, IMP-Imipenem, VAN-Vancomycin, DA-Clindamycin, LZ-Linezolid, CIP-Ciprofloxacin, GN-Gentamicin, PTZ-Piperacillin/Tazobactam.